In a transaction worth $650 million in pre-commercial payments, Daiichi Sankyo got exclusive US rights to Charleston Labs’ hydrocodone combos for pain; Roche acquired two of its partners, InterMune and Santaris. Both biopharma and device financing were down in August compared with July.
Exhibit 1
Top Alliances In August 2014
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.
J&J's EMEA head of digital solutions, Julia Fishman, talks about the hurdles in scaling digital innovation and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.
Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success.
